HC Wainwright Issues Positive Estimate for OVID Earnings
Ovid Therapeutics Inc. (NASDAQ:OVID – Free Report) – Equities researchers at HC Wainwright lifted their Q1 2025 EPS estimates for Ovid Therapeutics in a research note issued to investors on Monday, March 24th. HC Wainwright analyst R. Selvaraju now anticipates that the company will post earnings of ($0.13) per share for the quarter, up from […]
Ovid Therapeutics Inc. (NASDAQ:OVID – Free Report) – Equities researchers at HC Wainwright lifted their Q1 2025 EPS estimates for Ovid Therapeutics in a research note issued to investors on Monday, March 24th. HC Wainwright analyst R. Selvaraju now anticipates that the company will post earnings of ($0.13) per share for the quarter, up from […]
